Abstract
Introduction

42
The Zika virus (ZIKV) is currently causing an ongoing pandemic, incurring considerable human impact. The rapid DeNovo is a host-virus PPI prediction tool tailored to predict cross-species protein interactions for newly identified viral organisms for which no interaction data are previously known [25] . Given the lack of known interactions for the of the human host's proteins to inform its predictions [25] . Learning these characteristics in the commonly shared 88 human host, across all known host-viral interactions, enhances the discovery of interactions in the organism of interest.
89
Determining the high confidence interactions as those with a probability of interaction greater than or equal to 80% 90 resulted in 871 human-ZIKV interactions (0.38% of all putative PPIs) corresponding to 186 candidate human proteins 91 (supplementary table 1 ). From these 186 candidates, we performed a literature search on eight due to their relevance 92 to ZIKV infection to supplement the 17 from the PIPE analysis.
93
Prediction of PPI-Sites
94
The list of PPIs generated from both methods can be used to inform the design of anti-ZIKV therapeutics by using 95 peptide sequences from the predicted PPI site, which we refer to as the PPI-Site. We define the PPI-Site as the peptide 96 sequence that is responsible for mediating the PPIs. When PIPE predicts an interaction between the two corresponding 97 proteins, it will also report the predicted site of interaction using the amino acid sequences from both proteins. Using 98 our previously reported PIPE output, we selected for PIPE's built-in peak height attribute, which we refer to as H.
99
This is a measure of the number of times two corresponding sequence pairs co-occur within the annotated database of 100 known PPI normalized to its expected occurrence. Selecting for H within our top 17 interactions produced 4 human-
101
ZIKV PPI-Sites which we believe mediate the human-ZIKV PPIs.
Results
103
To generate a list of anti-ZIKV peptides, we first predicted a network of PPIs between humans and the ZIKV. This 
109
between proteins from a host and newly discovered viral organisms independent of prior known host-virus interactions 110 [25] . Figure 1 highlights the ontology classification of the 209 human proteins believed to participate in human-ZIKV peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/156695 doi: bioRxiv preprint first posted online Jun. 29, 2017; protein (and their associated ZIKV interactors) from our list of 209 candidates based on their correlation to known 113 mechanisms of ZIKV infection, pathology, and symptomology. Of the eleven ZIKV proteins considered, the nine 114 interacting proteins reported in our results correspond to the structural proteins: Envelope (E), Capsid (C),
115
Premembrane (Pr), and Membrane (M), and the non-structural proteins: NS1, NS2A, NS3, NS4B, and the RNA-116 dependent RNA polymerase NS5 proteins. These proteins not only highlight protein candidates for PPI-based 117 therapeutic design, but also they may provide potential mechanisms of ZIKV infection. supplementary table 1   123   124 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/156695 doi: bioRxiv preprint first posted online Jun. 29, 2017; [54] SNAP25 (N) NS4B, M Huntington's Disease (D) [55] YWHAE (N) NS4B Neurocognitive, Cerebrospinal fluid marker (D) [56] COX17 (N) NS4B, NS2A Cardiomyopathy, hepatic failure (D) [57] SPZ1 (N) NS4B, M Spermatogenesis (F) [58] DNAJA1 (N) Pr, M Testis development, spermatogenesis (F) [59] * indicates interaction pairs also predicted for the Dengue virus.
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/156695 doi: bioRxiv preprint first posted online Jun. 29, 2017; From the list of 25 candidates, we here examine a subset of four proteins -RNASET2, ENO2, TRAF4, and CEP63 of of microcephaly [33] which is of special interest as no proposed mechanism exists linking the ZIKV to microcephaly.
129
The second candidate, ENO2, has been linked to early brain development of humans [60] , and may be useful in the 130 study the pathogenesis of possible ZIKV-associated neurological disorders. TRAF4 is our third candidate and has 131 been reported to be involved in TNF-receptor activity [46] . We believe that interfering with this receptor may affect
132
ZIKV absorption and/or release. Finally, CEP63 has been previously implicated in p53 dependent microcephaly [52] .
a ZIKV interaction with CEP63 may prove useful. We identified the site of interactions (PPI-Site) between these 135 proteins and their ZIKV interacting partners (table 2). Overproduction of these PPI-Sites via synthetic peptides can
136
interfere with human-ZIKV PPIs, potentially acting as competitive inhibitors against the corresponding ZIKV protein.
137
Consequently, PPI-Sites can provide the basis for effective anti-ZIKV therapeutics. We predicted an interaction between the human protein RNASET2 and the ZIKV serine protease NS3. Interestingly,
175
two Flaviviridae (Hepatitis C and Dengue) have been found to interact with human RNASET2 protein via their NS3 176 protein in vitro [64] . The proteolytic domain of the ZIKV NS3 serine protease occurs at residues 1-175 [65, 66] , and
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RNASET2 is a proteolytic target at residue 24-25, which when cleaved produces a signaling peptide and the functional 178 The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/156695 doi: bioRxiv preprint first posted online Jun. 29, 2017; moves to the cell membrane. 5: The ZIKV particle exits the host cell. P3 may also interfere with these last two steps.
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The ENO2 interaction with NS5 may impact neurodevelopment. This is the proposed site of P2 activity. The predicted peer 
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